12
Views
2
CrossRef citations to date
0
Altmetric
Review

Current therapies for prophylaxis of pediatric migraine

Pages 555-559 | Published online: 10 Jan 2014

References

  • Abu-Arefeh I, Russell G. Prevalence of headache and migraine in school children. Br. Med 309, 765–769 (1984).
  • Stewart WE Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. JAIVIA 267, 64–69 (1992).
  • Hockaday J. Management of migraine. Arch. Dis. Chi1cI65, 1174–1176 (1990).
  • Hershey AD, Powers SW, Bentti AL, de Graw TJ. Effectiveness of amitriptiline in the prophylactic management of childhood headaches. Headache 40, 539–549 (2000).
  • ••Open-label study with amitriptyline inchildren with various headache types.
  • Vasconellos E, Pina-Garza J, Milan E, Warren J. Analgesic rebound headache in children and adolescents. j Child Neural 13, 443–447 (1998).
  • ••Details efficacy of amitryptiline inrefractory headaches.
  • KLapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 17, 103–108 (1997).
  • •Double-blind study with divalproex sodium in migraine prophylaxis.
  • Caruso JM, Brown WD, Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 40, 672–676 (2000).
  • ••Open-label study with divalproex inchildren.
  • Pakalnis, A, Greenberg G, Drake ME, Paolicchi J. Pediatric migraine prophylaxis with divalproex. J. Child Neural. 16, 731–734 (2001).
  • ••This open-label study suggests divalproex may be less effective in children with comorbid behavioral disorders.
  • Krymchantowski AU, Nobre ME, Morcira P. Low-dose flunarizine for the prevention of migraine in children. Headache 11, 119–121 (2001).
  • ••Details usage of flunarizine, a calciumchannel blocker, in migraine prophylaxis.
  • Bille B, Ludvigsson J, Sanner G. Prophylaxis of migraine in children. Headache 17, 61–63 (1977).
  • Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neural. Land. 50, 109–115 (1974).
  • Burstein R, Yamamura H, Malick A. eta]. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation brain stem trigeminal neurons. I Neurophysiol 79, 964–982 (1998).
  • Goadsby PJ. Neuroimaging headache from the inside. aphalalgla 20, 275 (2000).
  • •Elaborates on recent research in pathophysiology of migraine.
  • Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. Neurology 50, 466–470 (1998).
  • •Novel study of double-blind design with this B2 therapy.
  • Aaltonen K, Hamalainen ML, Hoppu K. Children's response to placebo in migraine attacks. Cephalalgia 20, 385 (2000).
  • Vogler BK, Pittler MET, Ernst E. Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgla 18, 704–708 (1998).
  • Facchinetti F, Sances G, Borella P eta]. Magnesium prophylaxis of menstrual migraine: effects on intra cellula magnesium. Headache 31, 298–301 (1991).
  • Storey JR, Calder CS, Hard BE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 41, 968–975 (2001).
  • •New AED (topirarnate) appears to have efficacy in migraine prevention in adults.
  • Drake, ME, Greathouse NI, Armentbright, AD, Renner JB. Leveteracetam for preventive treatment of migraine. Cephalalgia 21, 373 (2001).
  • Mathew NT, Rapoport A, Saper J etal Efficacy of gabapentin in migraine prophylaxis. Headache 41, 119–128 (2001).
  • •AED with utility in migraine prevention and chronic pain in adults.
  • Freitag F, Diamond S, Diamond M. Tiagabine in the prophylaxis of migraine. Neumlogy52, A208 (1999).
  • Symon DNK. Prophylactic therapy. Cephalalgia 20, 284 (2000).
  • Maytal J, Young M, Schechter A, Lipton RB. Pediatric migraine and the International Headache Society (IHS) Criteria. Neurology 48, 602–607 (1997).
  • •Highlights recent developments in revising criteria for diagnosis of childhood migraine.
  • Freitag F, Saper J, Winner P eta]. Depakote ER in migraine prophylaxis. Neurology 54\(Suppl. 3) (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.